- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03338660
Platelet Function With Various Storage Techniques
May 24, 2019 updated by: Northwell Health
The Impact of Various Storage Techniques on Platelet Function
Platelet function will be tested in individuals on antiplatelet medications to determine the optimal storage methodology.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Subjects will undergo administration of antiplatelet drugs and then will receive platelets stored in a variety of methods.
Platelet function will be measured serially.
Study Type
Interventional
Phase
- Phase 2
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Normal subjects
Exclusion Criteria:
- Pre existing antiplatelet drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control (Placebo)
Subjects will receive infusion of placebo (saline).
|
Subjects will receive infusion placebo (saline).
Other Names:
|
Active Comparator: Platelet storage routine
Subjects will receive infusion of platelets stored by routine method.
|
Platelets will be stored using novel, FDA approved, technique.
Subjects will receive infusion of platelets stored by novel technique, routine storage, and placebo (saline).
Other Names:
Platelets will be stored using the routine platelet storage method.
Subjects will receive infusion of platelets stored by routine storage method.
Other Names:
|
Experimental: Platelet storage experimental
Subjects will receive infusion of platelets stored by a novel methodology.
|
Platelets will be stored using novel, FDA approved, technique.
Subjects will receive infusion of platelets stored by novel technique, routine storage, and placebo (saline).
Other Names:
Platelets will be stored using the routine platelet storage method.
Subjects will receive infusion of platelets stored by routine storage method.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in platelet function
Time Frame: 1 hour post-transfusion
|
Frozen platelets will result in improvement in platelet function after transfusion.
|
1 hour post-transfusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 15, 2018
Primary Completion (Anticipated)
July 15, 2019
Study Completion (Anticipated)
July 15, 2020
Study Registration Dates
First Submitted
February 1, 2017
First Submitted That Met QC Criteria
November 8, 2017
First Posted (Actual)
November 9, 2017
Study Record Updates
Last Update Posted (Actual)
May 29, 2019
Last Update Submitted That Met QC Criteria
May 24, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 16-XXXX-SIUHN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Platelet Dysfunction Due to Drugs
-
The University of The West IndiesRecruiting
-
The University of The West IndiesCompletedPlatelet Dysfunction Due to DrugsTrinidad and Tobago
-
The University of The West IndiesCompletedPlatelet Dysfunction Due to DrugsTrinidad and Tobago
-
Hamilton Health Sciences CorporationUnknownAspirin | Platelet Dysfunction Due to Drugs | Ticagrelor | TransfusionCanada
-
IRCCS Policlinico S. DonatoCompletedBleeding | Platelet Dysfunction Due to DrugsItaly
-
Aggredyne, Inc.CompletedRisk Factor, Cardiovascular | Platelet Dysfunction Due to Drugs
-
BloodworksNational Blood FoundationUnknownBleeding | Platelet Dysfunction Due to Drugs | Platelet DysfunctionUnited States
-
Cardiff UniversityCompletedPlatelet Dysfunction Due to AspirinUnited Kingdom
-
George Washington UniversityCompletedPlatelet Dysfunction Due to AspirinUnited States
-
Aggredyne, Inc.CompletedPlatelet Dysfunction Due to Aspirin IngestionUnited States
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States